Remicade props up Mitsubishi Tanabe
This article was originally published in Scrip
Executive Summary
Net pharmaceutical sales at Mitsubishi Tanabe Pharma(MTP) in Japan slipped by 1% to ¥191.0 billion ($1.97 billion) in the first half to September 30th, hit by the general April price cut and pre-merger stocking by wholesalers in the previous year.